Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Dec;5(6):953-955.
doi: 10.21037/tau.2016.11.11.

Belatacept in renal transplantation-quo vadis?

Timm H Westhoff  1
Affiliations
Comment

Belatacept in renal transplantation-quo vadis?

Timm H Westhoff. Transl Androl Urol. 2016 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The author received research grants and/or payment for lectures, meeting expenses and/or brochure preparation from Astellas, Bayer, Bristol-Myers Squibb, Novartis, Hexal, Otsuka, Pfizer and Sanofi Aventis.

Comment in

Comment on

  • Belatacept and Long-Term Outcomes in Kidney Transplantation.
    Vincenti F, Rostaing L, Grinyo J, Rice K, Steinberg S, Gaite L, Moal MC, Mondragon-Ramirez GA, Kothari J, Polinsky MS, Meier-Kriesche HU, Munier S, Larsen CP. Vincenti F, et al. N Engl J Med. 2016 Jan 28;374(4):333-43. doi: 10.1056/NEJMoa1506027. N Engl J Med. 2016. PMID: 26816011 Clinical Trial.

References

    1. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154-69. 10.1161/01.CIR.0000095676.90936.80 - DOI - PubMed
    1. Ojo AO, Hanson JA, Wolfe RA, et al. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000;57:307-13. 10.1046/j.1523-1755.2000.00816.x - DOI - PubMed
    1. Kasiske BL. Epidemiology of cardiovascular disease after renal transplantation. Transplantation 2001;72:S5-8. 10.1097/00007890-200109271-00003 - DOI - PubMed
    1. Nankivell BJ, PʼNg CH, OʼConnell PJ, et al. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras. Transplantation 2016;100:1723-31. 10.1097/TP.0000000000001243 - DOI - PubMed
    1. Vincenti F, Charpentier B, Vanrenterghem Y, et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant 2010;10:535-46. 10.1111/j.1600-6143.2009.03005.x - DOI - PubMed

LinkOut - more resources